- Home
- TREX vs JAGX Comparison
TREX vs JAGX Comparison
Compare TREX & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TREX
- JAGX
- Stock Information
- Founded
- TREX 1996
- JAGX 2013
- Country
- TREX United States
- JAGX United States
- Employees
- TREX N/A
- JAGX N/A
- Industry
- TREX
- JAGX Biotechnology: Pharmaceutical Preparations
- Sector
- TREX
- JAGX Health Care
- Exchange
- TREX Nasdaq
- JAGX Nasdaq
- Market Cap
- TREX N/A
- JAGX 3.1M
- IPO Year
- TREX 1999
- JAGX N/A
- Fundamental
- Price
- TREX $59.99
- JAGX $4.67
- Analyst Decision
- TREX Buy
- JAGX
- Analyst Count
- TREX 17
- JAGX 0
- Target Price
- TREX $78.76
- JAGX N/A
- AVG Volume (30 Days)
- TREX 2.1M
- JAGX 39.3K
- Earning Date
- TREX 05-08-2025
- JAGX 03-31-2025
- Dividend Yield
- TREX N/A
- JAGX N/A
- EPS Growth
- TREX 10.59
- JAGX N/A
- EPS
- TREX 2.09
- JAGX N/A
- Revenue
- TREX $1,151,449,000.00
- JAGX $11,689,000.00
- Revenue This Year
- TREX $8.39
- JAGX $18.18
- Revenue Next Year
- TREX $8.49
- JAGX $40.06
- P/E Ratio
- TREX $27.97
- JAGX N/A
- Revenue Growth
- TREX 5.17
- JAGX 19.75
- 52 Week Low
- TREX $52.75
- JAGX $4.40
- 52 Week High
- TREX $97.69
- JAGX $540.00
- Technical
- Relative Strength Index (RSI)
- TREX 49.70
- JAGX 20.41
- Support Level
- TREX $55.90
- JAGX $4.41
- Resistance Level
- TREX $62.82
- JAGX $4.97
- Average True Range (ATR)
- TREX 2.18
- JAGX 0.88
- MACD
- TREX 0.46
- JAGX 0.09
- Stochastic Oscillator
- TREX 58.47
- JAGX 3.35
Stock Price Comparison Chart: TREX vs JAGX
■ TREX
■ JAGX
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.